{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:55:26Z","timestamp":1784332526486,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03629-6","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:38:43Z","timestamp":1744169923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Besharat","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6700-3570","authenticated-orcid":false,"given":"Niloofar","family":"Khoshnam Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahideh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsa","family":"Gholamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Roostaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Yousefi Mokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-0497","authenticated-orcid":false,"given":"Hamidreza","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"3629_CR1","doi-asserted-by":"publisher","unstructured":"Merhej T, Zein JG. Epidemiology of asthma: prevalence and burden of disease. InPrecision Approaches to Heterogeneity in Asthma 2023 Jul 19 (pp. 3-23). Cham: Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-031-32259-4_1","DOI":"10.1007\/978-3-031-32259-4_1"},{"key":"3629_CR2","unstructured":"GINA committee. Global strategy for asthma management and prevention 2024 update. Glob Initiat Asthma Published Online. 2024:225. https:\/\/ginasthma.org\/2024-report\/"},{"issue":"8","key":"3629_CR3","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Barjaktarevic IZ, et al. Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):E70\u201388. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3629_CR4","doi-asserted-by":"publisher","first-page":"2103179","DOI":"10.1183\/13993003.03179-2021","volume":"60","author":"K Mortimer","year":"2022","unstructured":"Mortimer K, Reddel HK, Pitrez PM, Bateman ED. Asthma management in low and middle income countries: case for change. Eur Respir J. 2022;60(3):2103179. https:\/\/doi.org\/10.1183\/13993003.03179-2021","journal-title":"Eur Respir J"},{"key":"3629_CR5","doi-asserted-by":"publisher","unstructured":"Gionfriddo MR, Hagan JB, Hagan CR, Volcheck GW, Castaneda-Guarderas A, Rank MA. Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: systematic review and meta-analysis. Allergy Asthma Proc. 2015;36(4):262\u2013267. https:\/\/doi.org\/10.2500\/aap.2015.36.3850","DOI":"10.2500\/aap.2015.36.3850"},{"key":"3629_CR6","doi-asserted-by":"publisher","unstructured":"Bloom CI, Ramsey H, Alter M et al. Qualitative study of practices and challenges of stepping down asthma medication in primary care across the UK. J Asthma Allergy. 2020;13:429\u201337. https:\/\/doi.org\/10.2147\/JAA.S274943","DOI":"10.2147\/JAA.S274943"},{"issue":"3","key":"3629_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.anai.2018.12.004","volume":"122","author":"BE Chipps","year":"2019","unstructured":"Chipps BE, Bacharier LB, Murphy KR, et al. The asthma controller step-down yardstick. Ann Allergy Asthma Immunol. 2019;122(3):241\u2013e2624. https:\/\/doi.org\/10.1016\/j.anai.2018.12.004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"3629_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2020.02.006","volume":"66","author":"H Wangberg","year":"2020","unstructured":"Wangberg H, White AA. Aspirin-exacerbated respiratory disease. Curr Opin Immunol. 2020;66:9\u201313. https:\/\/doi.org\/10.1016\/j.coi.2020.02.006","journal-title":"Curr Opin Immunol"},{"key":"3629_CR9","doi-asserted-by":"publisher","unstructured":"Ducharme F, di Salvio F. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and\/or chronic asthma in adults and children. Cochrane Database Syst Rev. Published online 2004. https:\/\/doi.org\/10.1002\/14651858.cd002314.pub2","DOI":"10.1002\/14651858.cd002314.pub2"},{"key":"3629_CR10","doi-asserted-by":"publisher","unstructured":"Ekhart C, van Hunsel F, Sellick V, de Vries T. Neuropsychiatric reactions with the use of montelukast. BMJ Published Online March. 2022;e067554. https:\/\/doi.org\/10.1136\/bmj-2021-067554","DOI":"10.1136\/bmj-2021-067554"},{"key":"3629_CR11","doi-asserted-by":"publisher","unstructured":"Mou Y, Song Q, Zhao C, Fang H, Ren C, Song X. Meta-analysis of the relationship between montelukast use and neuropsychiatric events in patients with allergic airway disease. Heliyon. 2023;9(11). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21842","DOI":"10.1016\/j.heliyon.2023.e21842"},{"issue":"4","key":"3629_CR12","first-page":"49","volume":"10","author":"N Sigari","year":"2011","unstructured":"Sigari N, Sigari N, Ghasri H, Rahimi E, Mohammadi S. Validation of Persian version of asthma control test based on new global initiative for asthma guidelines. Tanaffos. 2011;10(4):49\u201353.","journal-title":"Tanaffos"},{"issue":"4","key":"3629_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","volume":"124","author":"M Schatz","year":"2009","unstructured":"Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the asthma control test. J Allergy Clin Immunol. 2009;124(4):719\u2013e7231. https:\/\/doi.org\/10.1016\/j.jaci.2009.06.053","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3629_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4187\/respcare.04341","volume":"61","author":"YA Alzahrani","year":"2016","unstructured":"Alzahrani YA, Becker EA. Asthma control assessment tools. Respir Care. 2016;61(1):106\u201316. https:\/\/doi.org\/10.4187\/respcare.04341","journal-title":"Respir Care"},{"issue":"10","key":"3629_CR15","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.21037\/jtd.2019.09.62","volume":"11","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang M, Wen S, Yu L, Xu X. Types and applications of cough-related questionnaires. J Thorac Dis. 2019;11(10):4379\u201388. https:\/\/doi.org\/10.21037\/jtd.2019.09.62","journal-title":"J Thorac Dis"},{"issue":"7","key":"3629_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1183\/09031936.94.07071246","volume":"7","author":"J Hsu","year":"1994","unstructured":"Hsu J, Stone R, Logan-Sinclair R, Worsdell M, Busst C, Chung K. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J. 1994;7(7):1246\u201353. https:\/\/doi.org\/10.1183\/09031936.94.07071246","journal-title":"Eur Respir J"},{"issue":"10","key":"3629_CR17","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1016\/j.jaip.2021.04.042","volume":"9","author":"SH Kim","year":"2021","unstructured":"Kim SH, Lee T, Jang AS, et al. Pragmatic randomized controlled trial for stepping down asthma controller treatment in patients controlled with low-dose inhaled corticosteroid and long-acting \u03b22-agonist: step-down of intervention and grade in moderate asthma study. J Allergy Clin Immunol Pract. 2021;9(10):3638\u2013e36463. https:\/\/doi.org\/10.1016\/j.jaip.2021.04.042","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3629_CR18","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and strategy. Published online 2023."},{"key":"3629_CR19","doi-asserted-by":"publisher","unstructured":"Chauhan BF, Jeyaraman MM, Singh Mann A, et al. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. Cochrane Database Syst Rev. 2017;2017(3). https:\/\/doi.org\/10.1002\/14651858.CD010347.pub2","DOI":"10.1002\/14651858.CD010347.pub2"},{"issue":"10","key":"3629_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/crj.13629","volume":"17","author":"Q Xu","year":"2023","unstructured":"Xu Q, Lu T, Song Z, et al. Efficacy and safety of montelukast adjuvant therapy in adults with cough variant asthma: a systematic review and meta-analysis. Clin Respir J. 2023;17(10):986\u201397. https:\/\/doi.org\/10.1111\/crj.13629","journal-title":"Clin Respir J"},{"key":"3629_CR21","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhang W, Xu W. The effects of Montelukast sodium in conjunction with budesonide\/formoterol on pulmonary function and serum markers (interleukin-6, tumor necrosis factor-a, eosinophils (EOS) count) in obstructive airway diseases (asthma and chronic obstructive pulmonary. Adv Dermatology Allergol. Published online 2024. https:\/\/doi.org\/10.5114\/ada.2024.144825","DOI":"10.5114\/ada.2024.144825"},{"key":"3629_CR22","doi-asserted-by":"publisher","unstructured":"Wei Z, Li S. An efficacy and safety evaluation of montelukast\u2009+\u2009fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis. BMC Pulm Med. 2023;23(1). https:\/\/doi.org\/10.1186\/s12890-023-02721-z","DOI":"10.1186\/s12890-023-02721-z"},{"issue":"7","key":"3629_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/nejmx070043","volume":"357","author":"American Lung Association Asthma Clinical Research Centers","year":"2007","unstructured":"American Lung Association Asthma Clinical Research Centers. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med. 2007;357(7):728\u2013728. https:\/\/doi.org\/10.1056\/nejmx070043","journal-title":"N Engl J Med"},{"issue":"11","key":"3629_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0011-393X(01)80081-3","volume":"62","author":"DB Price","year":"2001","unstructured":"Price DB, Rouleau MY, Fletcher CP, et al. Use of montelukast in tapering inhaled corticosteroid therapy: an open-label, 48-week trial. Curr Ther Res - Clin Exp. 2001;62(11):743\u201355. https:\/\/doi.org\/10.1016\/S0011-393X(01)80081-3","journal-title":"Curr Ther Res - Clin Exp"},{"issue":"3","key":"3629_CR25","first-page":"285","volume":"35","author":"G Riccioni","year":"2005","unstructured":"Riccioni G, Della Vecchia R, Castronuovo M, Di Ilio C, D\u2019Orazio N. Tapering dose of inhaled budesonide in subjects with mild-to-moderate persistent asthma treated with montelukast: a 16-week single-blind randomized study. Ann Clin Lab Sci. 2005;35(3):285\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/16081585\/","journal-title":"Ann Clin Lab Sci"},{"issue":"6","key":"3629_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1067\/mai.2002.123869","volume":"109","author":"SJ Fowler","year":"2002","unstructured":"Fowler SJ, Currie GP, Lipworth BJ. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a\u2013beclomethasone alone. J Allergy Clin Immunol. 2002;109(6):929\u201335. https:\/\/doi.org\/10.1067\/mai.2002.123869","journal-title":"J Allergy Clin Immunol"},{"key":"3629_CR27","doi-asserted-by":"publisher","unstructured":"Lam NH, Nam NT, Vu LT, Vinh NN, Tuyet-Lan LT. Stepping down therapy for well-controlled mild asthma: an experience from university medical center at Ho Chi Minh City. Asia Pac Allergy. 2021;11(1). https:\/\/doi.org\/10.5415\/apallergy.2021.11.e9","DOI":"10.5415\/apallergy.2021.11.e9"},{"issue":"3","key":"3629_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1067\/mai.2002.122635","volume":"109","author":"SJ Szefler","year":"2002","unstructured":"Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109(3):410\u20138. https:\/\/doi.org\/10.1067\/mai.2002.122635","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"3629_CR29","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1378\/chest.124.6.2329","volume":"124","author":"FT Leone","year":"2003","unstructured":"Leone FT, Fish JE, Szefler SJ, West SL. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma. Chest. 2003;124(6):2329\u201340. https:\/\/doi.org\/10.1378\/chest.124.6.2329","journal-title":"Chest"},{"issue":"8","key":"3629_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1513\/AnnalsATS.201711-886OC","volume":"15","author":"E DiMango","year":"2018","unstructured":"DiMango E, Rogers L, Reibman J, et al. Risk factors for asthma exacerbation and treatment failure in adults and adolescents with well-controlled asthma during continuation and step-down therapy. Ann Am Thorac Soc. 2018;15(8):955\u201361. https:\/\/doi.org\/10.1513\/AnnalsATS.201711-886OC","journal-title":"Ann Am Thorac Soc"},{"key":"3629_CR31","doi-asserted-by":"publisher","unstructured":"Petsky HL, Li A, Chang AB. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2017;2017(8). https:\/\/doi.org\/10.1002\/14651858.CD005603.pub3","DOI":"10.1002\/14651858.CD005603.pub3"},{"key":"3629_CR32","doi-asserted-by":"publisher","unstructured":"Wang K, Verbakel JY, Oke J, et al. Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis. Eur Respir J. 2020;55(5). https:\/\/doi.org\/10.1183\/13993003.02150-2019","DOI":"10.1183\/13993003.02150-2019"},{"issue":"6","key":"3629_CR33","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","volume":"146","author":"MM Cloutier","year":"2020","unstructured":"Cloutier MM, Baptist AP, Blake KV, et al. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217\u201370. https:\/\/doi.org\/10.1016\/j.jaci.2020.10.003","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3629_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jaip.2023.01.002","volume":"11","author":"R Beasley","year":"2023","unstructured":"Beasley R, Bruce P, Houghton C, Hatter L. The ICS\/Formoterol reliever therapy regimen in asthma: a review. J Allergy Clin Immunol Pract. 2023;11(3):762\u2013e7721. https:\/\/doi.org\/10.1016\/j.jaip.2023.01.002","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"3629_CR35","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","volume":"199","author":"R Beasley","year":"2019","unstructured":"Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled corticosteroid therapy in adult asthma time for a new therapeutic dose terminology. Am J Respir Crit Care Med. 2019;199(12):1471\u20137. https:\/\/doi.org\/10.1164\/rccm.201810-1868CI","journal-title":"Am J Respir Crit Care Med"},{"key":"3629_CR36","doi-asserted-by":"publisher","unstructured":"Beasley R, Harper J, Bird G, Dunphy H, Semprini A, Pavord ID, et al. Dose-response relationship of ICS\/fast-onset LABA as reliever therapy in asthma. BMC Pulm Med. 2019;19:1\u20138. https:\/\/doi.org\/10.1186\/s12890-019-1014-4","DOI":"10.1186\/s12890-019-1014-4"},{"issue":"9","key":"3629_CR37","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/17476348.2021.1935245","volume":"15","author":"M Cazzola","year":"2021","unstructured":"Cazzola M, Matera MG, Rogliani P, Calzetta L, Ora J. Step-up and step-down approaches in the treatment of asthma. Expert Rev Respir Med. 2021;15(9):1159\u201368. https:\/\/doi.org\/10.1080\/17476348.2021.1935245","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"3629_CR38","doi-asserted-by":"publisher","first-page":"e000756","DOI":"10.1136\/bmjresp-2020-000756","volume":"7","author":"R Patel","year":"2020","unstructured":"Patel R, Naqvi SA, Griffiths C, Bloom CI. Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review. BMJ Open Respir Res. 2020;7(1):e000756. https:\/\/doi.org\/10.1136\/bmjresp-2020-000756","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"3629_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2500\/aap.2015.36.3863","volume":"36","author":"JL Zazzali","year":"2015","unstructured":"Zazzali JL, Broder MS, Omachi TA, Chang E, Sun GH, Raimundo K. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use. Allergy Asthma Proc. 2015;36(4):268\u201374. https:\/\/doi.org\/10.2500\/aap.2015.36.3863","journal-title":"Allergy Asthma Proc"},{"key":"3629_CR40","doi-asserted-by":"publisher","unstructured":"Diamant Z, Mantzouranis E, Bjermer L. Montelukast in the treatment of asthma and beyond. Expert Rev Clin Immunol. 2009;5(6):639\u201358. https:\/\/doi.org\/10.1586\/eci.09.62","DOI":"10.1586\/eci.09.62"},{"key":"3629_CR41","doi-asserted-by":"publisher","unstructured":"Lo CWH, Pathadka S, Qin SX, et al. Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review. Eur Respir Rev. 2023;32(169). https:\/\/doi.org\/10.1183\/16000617.0079-2023","DOI":"10.1183\/16000617.0079-2023"},{"issue":"8","key":"3629_CR42","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/bcp.13280","volume":"83","author":"TA Althunian","year":"2017","unstructured":"Althunian TA, de Boer A, Groenwold RH, Klungel OH. Defining the noninferiority margin and analysing noninferiority: an overview. Br J Clin Pharmacol. 2017;83(8):1636\u201342. https:\/\/doi.org\/10.1111\/bcp.13280","journal-title":"Br J Clin Pharmacol"},{"key":"3629_CR43","doi-asserted-by":"publisher","unstructured":"Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ. 2015;351. https:\/\/doi.org\/10.1136\/bmj.h4672","DOI":"10.1136\/bmj.h4672"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03629-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03629-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:35:48Z","timestamp":1744220148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03629-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3629"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03629-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and was approved by the Research Ethics Committee of Tehran University of Medical Sciences (TUMS) (Ethical code: 94-03-159-30560). Written and verbal informed consent was obtained from all participants prior to their enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was registered at IRCT.ir (Registration Code: IRCT2016052428037N1, Registration date: 2016-07-01). ().","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"B.R.: Conceptualization, Methodology, Project administration, Writing- review and editing; N.K.: Formal analysis, Investigation, Methodology, Validation, Writing\u2013 original draft, Writing\u2013 review & editing; S.A.: Data curation, Investigation, Project administration; M.G.: Formal analysis, Writing- review and editing; G.R.: Writing\u2013 original draft, Writing\u2013 review & editing; M.YM.: Methodology, Writing\u2013 review & editing; H.R: Conceptualization, Investigation, Methodology, Project administration, Supervision, Validation, Writing\u2013 review & editing.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution statement"}}],"article-number":"167"}}